CD1D and neoplasm: In a scenario characterized by a low tumor burden and the presence of BCMA+CD1d− tumor cells, Allo/U15BCAR-NKT cells exhibited a tumor cell elimination efficacy on a par with that of BCAR-T cells (Figures 5B and 5C).